MYC and colorectal cancer: This suggests that CCAL could increase the development of CRC by targeting and activating AP-2, that CCAT1-L plays a part in the control of MYC transcription and encourages lengthy chromatin looping, and that CCAT1-L is site-specific transcribed upstream of MYC in human colorectal cancer.